LDHB and breast carcinoma: Our current study has shown for the first time in human breast cancer that loss of expression of the LDH-B subunit may occur at an early (DCIS) stage, and occurs in a high frequency of breast cancers, with the underlying mechanism likely to involve methylation of the LDH-B promoter.